Skip to main content
Premium Trial:

Request an Annual Quote

Lunaphore Technologies Raises Additional $2.1M in Series C Financing

NEW YORK Lunaphore Technologies on Tuesday announced it has raised CHF 2 million ($2.1 million) in Series C2 financing, bringing the total revenues for its Series C round to CHF 25 million.

Swiss Entrepreneurs Fund invested all CHF 2 million in the Series C2 financing round, bringing its total investment in Lunaphore to CHF 5 million. The Swiss Entrepreneurs fund is linked to the Swiss Entrepreneurs Foundation, whose focus is to invest in Swiss startups and small- and medium-sized enterprises in a growth phase, Lunaphore said.

In February, the Lausanne, Switzerland-based company had announced it raised CHF 23 million in its Series C round.

The proceeds from the overall Series C financing will be dedicated to market and product expansion, including a US market entry, the ramp up of activities in Europe, and the development of next-generation instruments, the firm said.

Lunaphore is developing next-generation tissue autostainers that use microfluidics to perform assays on cancer patient tissue samples.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.